NNVC Stock Analysis: Buy, Sell, or Hold?
NNVC - NanoViricides Inc.
$1.65
0.14 (9.27%)
▲
5d:
+10.0%
30d:
+23.13%
90d:
+67.9%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When NNVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NNVC is 10.0% above its trading range ($1.50). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NNVC is 10.0% above its trading range ($1.50). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NNVC is currently trading at $1.65, which is considered extended relative to its 30-day fair value range of $1.31 to $1.50.
Technical Outlook: Technically, NNVC is in a strong uptrend. Immediate support is located at $1.35, while resistance sits at $1.93. The stock is showing strong short-term momentum, up 9.3% recently.
Market Sentiment: NNVC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+263.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NNVC is in a strong uptrend. Immediate support is located at $1.35, while resistance sits at $1.93. The stock is showing strong short-term momentum, up 9.3% recently.
Market Sentiment: NNVC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+263.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.31 -
$1.50
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+10.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.3%)
- BULLISH: Trading 263.6% below Wall St target ($6.00)
- CAUTION: Extended 10.0% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$1.31 -
$1.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.93
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.71
Wall Street Target
$6.00
(+263.6%)
Share & Embed Analysis
Last updated: July 13, 2026 6:13 PM ET
Data refreshes hourly during market hours. Next update: 7:13 PM
Data refreshes hourly during market hours. Next update: 7:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NNVC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 61 BUY |